首页 正文

Treatment Approaches for Omalizumab-Refractory Chronic Spontaneous Urticaria

{{output}}
Chronic spontaneous urticaria (CSU) is a mast cell-driven disease that impairs health-related quality of life. Although omalizumab is a cornerstone treatment for patients uncontrolled with up-dosed second-generation H1-antihistamines, some patients remain part... ...